All In MedTech

Company

Cardiovascular Systems

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$17.0M

3 Form D offerings, 2010 to 2011

Equity

$0

Stock sold for cash

Debt and convertible notes

$17.0M

$17.0M of it convertible

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: options or warrants, $40K raised, first sale May 23, 2011, 3 investors. $40K was in other or unstated securities.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
May 23, 2011Options or warrants$40KOpen-ended31 non-accreditedRule 506Form D ↗Jun 2, 2011

2 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
Cardiovascular Systems Inc
Headquarters
St. Paul, Minnesota
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
$25,000,001 - $100,000,000
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    13 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Cardiovascular Systems.

    Latest FDA decisions

    The 8 newest of 36 since 2015.

    Search the Clearance Tracker

    35 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    No device trials list this company as lead sponsor.

    Reports received

    835

    Received Nov 1, 2025 to Nov 20, 2026. Includes 2 of another or unstated type.

    Malfunction reports

    550

    66% of reports

    Injury reports

    233

    28% of reports

    Death reports

    50

    6.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 23331000
    Jan 24608330
    Feb 24461741
    Mar 24351730
    Apr 24393220
    May 24362110
    Jun 24364350
    Jul 24352040
    Aug 24474061
    Sep 24421610
    Oct 24471820
    Nov 24251820
    Dec 24251440
    Jan 25291440
    Feb 25281620
    Mar 25452410
    Apr 25392800
    May 25563830
    Jun 25361430
    Jul 25432460
    Aug 25422570
    Sep 25422220
    Oct 25532960
    Nov 25502120
    Dec 25412630
    Jan 2630820
    Feb 26241980
    Mar 26502750
    Apr 26552040
    May 26491630
    Jun 26462470
    Jul 26461960
    Aug 26391622
    Sep 26712130
    Oct 26491650
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    7 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    587 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.